Venture
Oncology Impact Fund 2, L.P.
Raising 2021-11-22Private Equity Fund · adviser (attributed) MPM Bioimpact
- CIK 1817314
- File 021-422030
- State MA
- 506(b)
- 3(c)(7)
- Sought
- Indefinite
- no ceiling stated
- Sold so far
- $327M
- as of 2021-11-22
- Investors
- 31
- reported
- Minimum investment
- $0
- no minimum, as filed
Connected
from Form D 021-422030Fund size — sought vs sold
No ceiling stated: the Form D answers "Indefinite", so $327M sold is the running total of subscriptions, not a share of a target.
Facts
As its latest Form D states them
- Fund type
- Private Equity Fund
- Adviser (attributed)
- MPM Bioimpact
- State
- Massachusetts (MA)
- Exemptions
- Rule 506(b); Investment Company Act Section 3(c)(7)
- First filed
- 2021-11-22
- Latest filing
- 2021-11-22
- First sale
- 2020-08-04
- Filings
- 1 Form D
People
Named in Item 3 of its latest Form D, filed 2021-11-22
| Name | Relationship | Clarification |
|---|---|---|
| MPM ONCOLOGY INVESTMENTS 2 LLC | RelationshipPromoter | ClarificationGENERAL PARTNER OF THE ISSUER. |
| ANSBERT GADICKE | RelationshipExecutive Officer | ClarificationMANAGING MEMBER OF THE GENERAL PARTNER OF THE ISSUER. |
Sales compensation
Named in Item 12 of its Form D filings
| Recipient | CRD | Broker-dealer | Offerings |
|---|---|---|---|
| UBS FINANCIAL SERVICES INC. | CRD8174 | Broker-dealer— | Offerings1 |
History
- 2021-11-22Form D filed · 021-422030
The other funds of MPM Bioimpact (14 on Form ADV) and every Form D as filedSee plans
The firm and the filings behind Oncology Impact Fund 2, L.P.
A fund's Form D states its target and what it has sold so far. The dashboard puts it beside the adviser's other funds from Form ADV, the startups linked to it, and every amendment as filed.
- The adviser's Venture page: its Form ADV funds, assets and other Form D offerings
- Where co-filings link it, the startups this fund backed
- Every Form D and amendment as filed, with what each one stated
- Everyone its filings name, linked to their other funds and companies
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗